NASDAQ · CCCC
C4 Therapeutics, Inc.
Healthcare · Biotechnology
$3.21
Down-$0.16 (-4.83%)
Updated Nov 4, 2026, 6:19 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 180.43M
- P/E ratio
- -1.54
- Dividend yield
- 0.00%
- 52-week range
- $2.30 – $5.17
- Volume
- 1.59M
- Avg. volume
- 2.1M
Price performance · CCCC
CCCC price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
CCCC closed at $3.21 after 21 trading sessions, up 11.46% for the selected period.
- Last close
- $3.21
- Period change
- +11.46%
- Period low
- $2.61
- Period high
- $3.40
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $3.27 | $3.42 | $3.17 | $3.21 | 1.59M |
| Nov 2, 2026 | $3.36 | $3.41 | $3.16 | $3.21 | 2.86M |
| Oct 30, 2026 | $3.23 | $3.38 | $3.21 | $3.37 | 2.35M |
| Oct 29, 2026 | $3.41 | $3.44 | $3.20 | $3.30 | 2.72M |
| Oct 28, 2026 | $3.25 | $3.53 | $3.23 | $3.395 | 4.11M |
| Oct 27, 2026 | $2.99 | $3.24 | $2.9501 | $3.21 | 4.12M |
| Oct 26, 2026 | $3.07 | $3.07 | $2.94 | $2.98 | 3.18M |
| Oct 23, 2026 | $3.16 | $3.17 | $3.02 | $3.06 | 4.74M |
| Oct 22, 2026 | $3.13 | $3.25 | $3.12 | $3.18 | 1.69M |
| Oct 21, 2026 | $3.15 | $3.22 | $3.10 | $3.17 | 2.19M |
| Oct 20, 2026 | $2.86 | $3.20 | $2.855 | $3.16 | 3.69M |
| Oct 19, 2026 | $2.80 | $2.94 | $2.80 | $2.89 | 3.11M |
| Oct 16, 2026 | $2.78 | $2.81 | $2.695 | $2.765 | 2.36M |
| Oct 15, 2026 | $2.64 | $2.846 | $2.60 | $2.78 | 3.28M |
| Oct 14, 2026 | $2.72 | $2.795 | $2.59 | $2.61 | 3.1M |
| Oct 13, 2026 | $3.04 | $3.06 | $2.75 | $2.78 | 3.82M |
| Oct 12, 2026 | $3.16 | $3.30 | $3.05 | $3.06 | 1.5M |
| Oct 9, 2026 | $3.00 | $3.1899 | $2.95 | $3.16 | 2.51M |
| Oct 8, 2026 | $2.80 | $2.88 | $2.7211 | $2.85 | 2.83M |
| Oct 7, 2026 | $2.85 | $2.95 | $2.82 | $2.82 | 2.27M |
| Oct 6, 2026 | $3.02 | $3.03 | $2.79 | $2.88 | 2.11M |
Latest CCCC news
The latest Smart Investors Daily articles mentioning CCCC.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

